Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT05477563 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease |
| Phase | Clinical Trial |
| Target Enrollment | 26 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | November 6, 2025 (Nov 6, 2025) |
As of March 2, 2026: Clinical trial NCT05477563 is currently recruiting participants. This clinical trial study for sickle cell disease is actively seeking new participants at 3 locations across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05477563 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05477563 was last updated Nov 6, 2025 (November 6, 2025). HelloStudys verifies this status automatically.